SILTISS
DEAD

Serial Number

87131672

Owner

SILTISS

Attorney

Jeffrey M. Goehring

Filing Date

Aug 9, 2016

Add to watchlist:

No watchlists yet
View on USPTO

SILTISS Trademark

Serial Number: 87131672 • Registration: 5254408

SILTISS is a trademark filed by SILTISS on August 9, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SILTISS (2 trademarks)

Rue des Fresnes
F-19240 SAINT-VIANCE , FR

Entity Type: 99

Trademark Details

Filing Date

August 9, 2016

Registration Date

August 1, 2017

Published for Opposition

May 16, 2017

Cancellation Date

February 16, 2024

Goods & Services

Pharmaceutical preparations for the prevention of tissue disability; Biological implants, namely, a vital processed human or animal connective tissue; Surgical implants comprised of living tissues; Implants comprising living tissue or Biological implants, namely, a vital processed human or animal connective tissue, for the restoration, regeneration or reinforcement of human tissue in the field of surgery, skin surgery, reconstructive surgery, bone surgery; Human tissue matrices for medical purposes; Human tissue membranes for medical purposes; Acellular human tissue matrices for use in surgery

Chemical substances, chemicals and chemical preparations, and natural elements, namely, biological tissue for analysis in laboratories, other than for medical or veterinary purposes; Raw materials and chemicals of natural origin, namely, biopolymers, biopolysaccharides, bioproteins, biopeptides, biosaccharides for the manufacture of reconstituted human tissue for use in scientific research; Raw materials and chemicals of natural origin derived from plants, microorganisms, fungi or algae, for the manufacture of reconstituted human tissue for use in scientific and medical research

Artificial limbs, bones, organs, eyes and teeth; Reconstituted artificial tissue for medical purposes; Reconstituted artificial tissue obtained by cell culture for medical purposes; Reconstituted artificial skin and/or epidermis for medical purposes; Reconstituted artificial human tissue matrices for medical purposes; Acellular synthetic tissue matrices for use in surgery

Research and development of new products in the field of medical devices, biomaterials and pharmaceuticals; Research and development of new products in the field of reconstituted human tissue; Research and development of new products in the field of biological and surgical implants; Surgical and medical research; Medical and surgical research relating to the repair, regeneration and strengthening of tissue; Tissue and cell engineering; Research in the field of surgery

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 16, 2024 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 18, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 18, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 18, 2022 REAP
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 1, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 1, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 11, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 7, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 7, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 7, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 7, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 7, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 5, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 29, 2016 GNRN
NON-FINAL ACTION E-MAILED
Nov 29, 2016 GNRT
NON-FINAL ACTION WRITTEN
Nov 29, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 19, 2016 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 6, 2016 AMPX
ASSIGNED TO LIE
Oct 2, 2016 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 23, 2016 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2016 NWOS
NEW APPLICATION ENTERED
Aug 12, 2016 NWAP